White Papers
Preventing Protein Instability
How I2F Reduces Bubbles to Mitigate Agitation-Induced Denaturation and Aggregation
Protein instability in biologics contributes to waste, inefficiency, and downstream cost exposure. This paper examines how air management during preparation may directly influence molecular stability and operational performance.
Reducing Hypersensitivity
Reactions in Immunoglobulin Therapy with I2F
This white paper examines the relationship between air bubble introduction during immunoglobulin (IG) preparation and the formation of protein aggregates that may contribute to infusion-related reactions. It reviews clinical literature on aggregation-driven immune activation and explores how delivery-phase air management may influence protein stability during administration. The analysis considers the potential role of controlled air equilibrium in supporting more stable preparation practices across infusion settings.
Reducing the Risk of IVIG-Associated Aseptic Meningitis:
The Role of Air Bubble Elimination and Protein Stability in Infusion Practices
This white paper examines potential mechanistic links between air exposure, protein instability, and infusion-related inflammatory responses during IVIG administration. It reviews supporting literature and clinical observations to explore how delivery-phase variables—particularly air bubble formation—may influence preparation stability. The analysis considers whether improved air management during infusion workflows may support more consistent and stable medication delivery practices.
I2F: Enhancing Biologic Safety and Reducing Cost
A Value Proposition for Insurers
This white paper examines the potential economic and risk-management implications of delivery-phase protein instability in biologic therapies. It explores how agitation and air exposure during preparation may contribute to variability, waste, and downstream cost exposure. The analysis considers whether improved air management during vial access may support more consistent administration practices and reduce avoidable inefficiencies within infusion workflows.
Microplastics in Medication Delivery
Plastic Device Exposure and a Stainless Steel Alternative
This white paper reviews emerging evidence that plastic-based medical delivery systems may contribute to microplastic and particulate exposure during infusion and injection workflows. It examines published literature on device-related particle shedding and considers the implications of direct-to-bloodstream exposure in medically vulnerable populations. The analysis explores material selection as a delivery-phase variable and evaluates stainless steel medication access as a potential mitigation strategy.